Clinical Trial Update: 68Ga-N188 PET/CT Imaging in Malignancy [NA]

View source ↗

Summary

This is a clinical trial update for a study assessing 68Ga-N188 PET/CT imaging in malignancy. The sponsor is Peking University First Hospital and the trial is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms

Drugs mentioned

• 68Ga-N188 PET/CT imaging radiotracer (68Ga-N188)

Snippet

Sponsor: Peking University First Hospital | Conditions: Neoplasms | NA | Status: RECRUITING